Arrowhead Accumulated Other Comprehensive Income from 2010 to 2024
| ARWR Stock | USD 24.88 0.21 0.85% |
Accumulated Other Comprehensive Income | First Reported 1998-03-31 | Previous Quarter -1.3 M | Current Value -1.1 M | Quarterly Volatility 1.2 M |
Check Arrowhead Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 20 M or Selling General Administrative of 79.1 M, as well as many exotic indicators such as Price To Sales Ratio of 10.19, Dividend Yield of 0.0 or PTB Ratio of 4.8. Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharmaceuticals Valuation or Volatility modules.
Arrowhead | Accumulated Other Comprehensive Income |
Latest Arrowhead Pharmaceuticals' Accumulated Other Comprehensive Income Growth Pattern
Below is the plot of the Accumulated Other Comprehensive Income of Arrowhead Pharmaceuticals over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Arrowhead Pharmaceuticals' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arrowhead Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Accumulated Other Comprehensive Income | 10 Years Trend |
|
Accumulated Other Comprehensive Income |
| Timeline |
Arrowhead Accumulated Other Comprehensive Income Regression Statistics
| Arithmetic Mean | (1,232,423) | |
| Geometric Mean | 262,868 | |
| Coefficient Of Variation | (125.15) | |
| Mean Deviation | 1,375,903 | |
| Median | (136,425) | |
| Standard Deviation | 1,542,324 | |
| Sample Variance | 2.4T | |
| Range | 4.2M | |
| R-Value | (0.12) | |
| Mean Square Error | 2.5T | |
| R-Squared | 0.01 | |
| Significance | 0.67 | |
| Slope | (40,844) | |
| Total Sum of Squares | 33.3T |
Arrowhead Accumulated Other Comprehensive Income History
About Arrowhead Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Arrowhead Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Arrowhead Pharmaceuticals investors use historical funamental indicators, such as Arrowhead Pharmaceuticals's Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Arrowhead Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arrowhead Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arrowhead Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arrowhead Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -2.9 M | -2.8 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Arrowhead Pharmaceuticals Correlation against competitors. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (4.23) | Revenue Per Share 0.319 | Quarterly Revenue Growth (0.94) | Return On Assets (0.32) |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.